Monte Rosa Therapeutics Inc (GLUE)
5.18
-0.04
(-0.77%)
USD |
NASDAQ |
May 17, 16:00
5.18
0.00 (0.00%)
Pre-Market: 20:00
Monte Rosa Therapeutics Price to Book Value: 1.722 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.722 |
| May 16, 2024 | 1.729 |
| May 15, 2024 | 1.732 |
| May 14, 2024 | 1.656 |
| May 13, 2024 | 1.639 |
| May 10, 2024 | 1.606 |
| May 09, 2024 | 1.716 |
| May 08, 2024 | 1.742 |
| May 07, 2024 | 1.881 |
| May 06, 2024 | 1.908 |
| May 03, 2024 | 1.864 |
| May 02, 2024 | 1.848 |
| May 01, 2024 | 1.96 |
| April 30, 2024 | 1.755 |
| April 29, 2024 | 1.851 |
| April 26, 2024 | 1.759 |
| April 25, 2024 | 1.798 |
| April 24, 2024 | 1.805 |
| April 23, 2024 | 1.828 |
| April 22, 2024 | 1.815 |
| April 19, 2024 | 1.930 |
| April 18, 2024 | 1.953 |
| April 17, 2024 | 1.914 |
| April 16, 2024 | 1.995 |
| April 15, 2024 | 2.162 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.373 |
| April 11, 2024 | 2.360 |
| April 10, 2024 | 2.360 |
| April 09, 2024 | 2.587 |
| April 08, 2024 | 2.472 |
| April 05, 2024 | 2.327 |
| April 04, 2024 | 2.314 |
| April 03, 2024 | 2.281 |
| April 02, 2024 | 2.238 |
| April 01, 2024 | 2.350 |
| March 31, 2024 | |
| March 28, 2024 | 1.973 |
| March 27, 2024 | 1.970 |
| March 26, 2024 | 1.844 |
| March 25, 2024 | 2.367 |
| March 22, 2024 | 2.157 |
| March 21, 2024 | 2.124 |
| March 20, 2024 | 2.084 |
| March 19, 2024 | 1.936 |
| March 18, 2024 | 1.875 |
| March 15, 2024 | 1.794 |
| March 14, 2024 | 1.704 |
| March 13, 2024 | 1.861 |
| March 12, 2024 | 1.701 |
| March 11, 2024 | 1.740 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6783
Minimum
Oct 25 2023
5.489
Maximum
Sep 03 2021
1.765
Average
1.529
Median
Price to Book Value Benchmarks
| Biogen Inc | 2.207 |
| Ionis Pharmaceuticals Inc | 18.37 |
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 2.107 |
| IGC Pharma Inc | 3.942 |
Price to Book Value Related Metrics
| Price | 5.18 |
| Earnings Yield | -48.46% |
| Market Cap | 262.66M |